Last reviewed · How we verify
Levadil (DILEVALOL)
At a glance
| Generic name | DILEVALOL |
|---|---|
| Drug class | dilevalol |
| Target | Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Beta-1 adrenergic receptor |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
| First approval | 1990 |
Approved indications
Common side effects
Key clinical trials
- Safest Choice of Antihypertensive Regimen for Postpartum Hypertension (PHASE3)
- Hypotensive Anesthesia for Orthognathic Surgery (PHASE4)
- Preeclampsia Postpartum Antihypertensive Treatment (PHASE3)
- Dexmedetomidine vs Labetalol for Airway Stress in Hypertensive Craniotomy Patients (PHASE4)
- Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
- Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia. (NA)
- Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial (PHASE4)
- Postpartum Management of Gestational Hypertensive Disorders Using Furosemide (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |